CCL7 and tuberculosis: MCP-3 (CCL7) recruits immune cells for protective immunity and has potential utility in differentiating LTBI from active tuberculosis, particularly in immunocompromised populations (Saunders et al., 2005; Ryan et al., 2007; Juno et al., 2016; Yao et al., 2017).